Skip to main content
SpringerLink
Log in

Cytogenetic study of secondary malignancy in giant cell tumor

  • Case Report
  • Published:
Journal of Orthopaedic Science

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Rock MG, Sim FH, Unni KK, Witrak GA, Frassica FJ, Schray MF, Beabout JW, Dahlin DC. Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg Am. 1986;68:1073–9.

    CAS  PubMed  Google Scholar 

  2. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–14.

    CAS  PubMed  Google Scholar 

  3. Schwartz HS, Jenkins RB, Dahl RJ, Dewald GW. Cytogenetic analyses on giant-cell tumors of bone. Clin Orthop Relat Res. 1989;240:250–60.

    PubMed  Google Scholar 

  4. Bridge JA, Neff JR, Bhatia PS, Sanger WG, Murphey MD. Cytogenetic findings and biologic behavior of giant cell tumors of bone. Cancer. 1990;65:2697–703.

    Article  CAS  PubMed  Google Scholar 

  5. Saâda E, Peoc’h M, Decouvelaere AV, Collard O, Peyron AC, Pedeutour F. CCND1 and MET genomic amplification during malignant transformation of a giant cell tumor of bone. J Clin Oncol. 2011;29:e86–9.

    Article  PubMed  Google Scholar 

  6. Murnane JP. Telomere dysfunction and chromosome instability. Mutat Res. 2012;730:28–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, Sápi Z. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes Chromosom Cancer. 2009;48:468–79.

    Article  CAS  PubMed  Google Scholar 

  8. Moskovszky L, Dezsö K, Athanasou N, Szendröi M, Kopper L, Kliskey K, Picci P, Sápi Z. Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability. Mod Pathol. 2010;23:359–66.

    Article  PubMed  Google Scholar 

  9. Unni KK, Inwards CY. Dahlin’s bone tumors. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.

    Google Scholar 

  10. Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R, Hogendoorn P, Kroep J, Wass J, Athanasou N. Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer. 2010;10:462.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br. 2004;86:212–6.

    Article  CAS  PubMed  Google Scholar 

  12. Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP. Giant cell tumor of bone. Am J Clin Oncol. 2006;29:96–9.

    Article  PubMed  Google Scholar 

  13. Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M. Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010;36:1–7.

    Article  PubMed  Google Scholar 

  14. Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012;94:461–7.

    Article  PubMed  Google Scholar 

  15. Shen CC, Li H, Shi ZL, Tao HM, Yang ZM. Current treatment of sacral giant cell tumour of bone: a review. J Int Med Res. 2012;40:415–25.

    Article  CAS  PubMed  Google Scholar 

  16. Balke M, Henrichs MP, Gosheger G, Ahrens H, Streitbuerger A, Koehler M, Bullmann V, Hardes J. Giant cell tumors of the axial skeleton. Sarcoma. 2012;2012:410973.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Oda Y, Miura H, Tsuneyoshi M, Iwamoto Y. Giant cell tumor of bone: oncological and functional results of long-term follow-up. Jpn J Clin Oncol. 1998;28:323–8.

    Article  CAS  PubMed  Google Scholar 

  18. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer. 2003;97:2520–9.

    Article  PubMed  Google Scholar 

  19. Schwartz HS, Butler MG, Jenkins RB, Miller DA, Moses HL. Telomeric associations and consistent growth factor overexpression detected in giant cell tumor of bone. Cancer Genet Cytogenet. 1991;15:263–76.

    Article  Google Scholar 

  20. Zheng MH, Siu P, Papadimitriou JM, Wood DJ, Murch AR. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone. Pathology. 1999;31:373–8.

    Article  CAS  PubMed  Google Scholar 

  21. Gorunova L, Vult von Steyern F, Storlazzi CT, Bjerkehagen B, Follerås G, Heim S, Mandahl N, Mertens F. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations. Genes Chromosom Cancer. 2009;48:583–602.

    Article  CAS  PubMed  Google Scholar 

  22. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer. 1995;75:1094–9.

    Article  CAS  PubMed  Google Scholar 

  23. Forsyth RG, De Boeck G, Bekaert S, De Meyer T, Taminiau AH, Uyttendaele D, Roels H, Praet MM, Hogendoorn PC. Telomere biology in giant cell tumour of bone. J Pathol. 2008;214:555–63.

    Article  CAS  PubMed  Google Scholar 

  24. Gebre-Medhin S, Broberg K, Jonson T, Gorunova L, von Steyern FV, Brosjö O, Jin Y, Gisselsson D, Panagopoulos I, Mandahl N, Mertens F. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone. Cytogenet Genome Res. 2009;124:121–7.

    Article  CAS  PubMed  Google Scholar 

  25. Sawyer JR, Goosen LS, Binz RL, Swanson CM, Nicholas RW. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone. Cancer Genet Cytogenet. 2005;159:32–6.

    Article  CAS  PubMed  Google Scholar 

  26. Lackman RD, Khoury LD, Esmail A, Donthineni-Rao R. The treatment of sacral giant-cell tumours by serial arterial embolisation. J Bone Joint Surg Br. 2002;84:873–7.

    Article  CAS  PubMed  Google Scholar 

  27. Lin PP, Guzel VB, Moura MF, Wallace S, Benjamin RS, Weber KL, Morello FA Jr, Gokaslan ZL, Yasko AW. Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization. Cancer. 2002;95:1317–25.

    Article  PubMed  Google Scholar 

  28. Hosalkar HS, Jones KJ, King JJ, Lackman RD. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine. 2007;32:1107–15.

    Article  PubMed  Google Scholar 

  29. Oda Y, Sakamoto A, Saito T, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M. Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation. Histopathology. 2001;39:629–37.

    Article  CAS  PubMed  Google Scholar 

  30. Rao UN, Goodman M, Chung WW, Swalski P, Pal R, Finkelstein S. Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet. 2005;158:126–36.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors greatly appreciate the help of Hiroko Nagano at the Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, for genetic analysis of the p53 mutation.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Author notes

  1. Taketsugu Fujibuchi

    Present address: Department of Bone and Joint Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan

Authors and Affiliations

  1. Department of Orthopaedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan

    Taketsugu Fujibuchi, Seiichi Matsumoto, Takashi Shimoji, Keisuke Ae, Taisuke Tanizawa, Tabu Gokita & Keiko Hayakawa

  2. Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan

    Noriko Motoi

  3. FML Laboratory Tokyo, 1-20-8 Kamiikedai, Ohta, Tokyo, 145-0064, Japan

    Hiroyuki Mukai

Authors
  1. Taketsugu Fujibuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiichi Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Shimoji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keisuke Ae
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taisuke Tanizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tabu Gokita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keiko Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Noriko Motoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroyuki Mukai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taketsugu Fujibuchi.

About this article

Cite this article

Fujibuchi, T., Matsumoto, S., Shimoji, T. et al. Cytogenetic study of secondary malignancy in giant cell tumor. J Orthop Sci 20, 217–223 (2015). https://doi.org/10.1007/s00776-013-0446-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-013-0446-6

Keywords

Search

Navigation